Methyl morpholine oxide → 3-(2-Ethoxy-3,5-diisopropyl-phenyl)-imidazo[1,2-a]pyridine-6-carbaldehyde
Reaction equation
C[N+]1([O-])CCOCC1.[CH2:9]([O:11][C:12]1[C:17]([CH:18]([CH3:20])[CH3:19])=[CH:16][C:15]([CH:21]([CH3:23])[CH3:22])=[CH:14][C:13]=1[C:24]1[N:28]2[CH:29]=[C:30]([CH2:33][OH:34])[CH:31]=[CH:32][C:27]2=[N:26][CH:25]=1)[CH3:10]>ClCCl.[Ru]([O-])(=O)(=O)=O.C([N+](CCC)(CCC)CCC)CC>[CH2:9]([O:11][C:12]1[C:17]([CH:18]([CH3:19])[CH3:20])=[CH:16][C:15]([CH:21]([CH3:23])[CH3:22])=[CH:14][C:13]=1[C:24]1[N:28]2[CH:29]=[C:30]([CH:33]=[O:34])[CH:31]=[CH:32][C:27]2=[N:26][CH:25]=1)[CH3:10]Participants
5
Procedure
Tetrapropylammonium perruthenate (24 mg, 0.07 mmol) and 4-methylmorpholine N-oxide (239.3 mg, 2.04 mmol) were added to a solution of [3-(2-ethoxy-3,5-diisopropyl-phenyl)-imidazo[1,2-a]pyridin-6-yl]-methanol (480 mg, 1.36 mmol) in dichloromethane under an atmosphere of nitrogen. After 3 h, the reaction was filtered through celite and evaporated. The residue used without further purification.
Workup
- filtrationthe reaction was filtered through celite
- customevaporated
- customThe residue used without further purification
Sources & evidence
- ORD record
- ord-408273f4821a4c6ca80161009035dabb
- Source dataset
- uspto-grants-2008_03
- Patent number
- US07348359B2
Reaction notes
Loading…